Trial
NCT04575766
A Study of FT-7051 in Men With MCRPC
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Novo Nordisk A/S
Collaborators
—
Condition
Metastatic Castration-resistant Prostate Cancer
Intervention
FT-7051
Why stopped
Sponsor Decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-08-09